BioAge Labs, Inc.·4

Feb 20, 4:17 PM ET

Fortney Kristen 4

4 · BioAge Labs, Inc. · Filed Feb 20, 2025

Insider Transaction Report

Form 4
Period: 2025-02-18
Fortney Kristen
DirectorChief Executive Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2025-02-18+530,000530,000 total
    Exercise: $4.38Exp: 2035-02-17Common Stock (530,000 underlying)
Footnotes (1)
  • [F1]The option vested or vests as to 1/48th of the total award monthly, with the first tranche vesting on February 1, 2025, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date.

Documents

1 file
  • 4
    form4-02202025_090259.xmlPrimary